Healthcare Sector Stocks
The Healthcare sector has a total of 1045 stocks, with a combined market cap of $9.17 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.49.
Market Cap
9.17T
Revenue
4.67T
Profits
189.18B
PE Ratio
48.49
Profit Margin
4.05%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -0.13% | 740,871 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 645.35B | 0.22% | 2,324,411 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 463.25B | -0.34% | 1,547,802 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 355.17B | 0.12% | 3,270,826 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 339.16B | 0.51% | 2,124,954 | 450.53B |
| 6 | NVS | Novartis AG | 265.19B | 0.17% | 1,427,164 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 253.42B | 0.34% | 2,177,529 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 239.82B | 1.12% | 1,577,715 | 46.34B |
| 9 | AMGN | Amgen Inc. | 203.61B | 0.26% | 935,740 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 188.46B | -2.14% | 7,873,243 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 182.79B | 0.77% | 2,188,092 | 30.46B |
| 12 | ABT | Abbott Laboratories | 177.49B | 0.53% | 2,648,331 | 46.59B |
| 13 | PFE | Pfizer Inc. | 156.23B | -0.51% | 13,039,327 | 63.70B |
| 14 | DHR | Danaher Corporation | 147.46B | 0.19% | 1,958,139 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 135.31B | 1.55% | 1,168,548 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.21B | -0.17% | 323,690 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.81B | -0.28% | 3,622,031 | 49.19B |
| 18 | MDT | Medtronic plc | 119.07B | -0.70% | 3,616,768 | 37.54B |
| 19 | CVS | CVS Health Corporation | 117.88B | -2.46% | 3,530,078 | 412.65B |
| 20 | SYK | Stryker Corporation | 110.15B | 2.01% | 1,902,883 | 25.84B |
| 21 | MCK | McKesson Corporation | 103.89B | -0.94% | 395,790 | 410.98B |
| 22 | SNY | Sanofi | 102.79B | 0.59% | 1,837,522 | 55.89B |
| 23 | GSK | GSK plc | 100.18B | 0.30% | 1,695,661 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 93.40B | 1.79% | 532,468 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 89.99B | -0.62% | 391,616 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.75B | 0.58% | 178,852 | 15.53B |
| 27 | CI | The Cigna Group | 74.73B | -2.10% | 506,148 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 64.03B | 0.71% | 7,583,320 | 21.00B |
| 29 | ARGX | argenx SE | 61.24B | 0.42% | 161,556 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.12B | -0.93% | 397,892 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.20B | -0.24% | 1,755,475 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 57.52B | 0.22% | 5,678,420 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.31B | 0.38% | 417,363 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.12B | 3.43% | 2,516,757 | 6.51B |
| 35 | NTRA | Natera, Inc. | 50.23B | -0.65% | 716,014 | 2.71B |
| 36 | BDX | Becton, Dickinson and Company | 49.78B | -1.71% | 538,181 | 22.48B |
| 37 | HUM | Humana Inc. | 46.39B | -2.59% | 488,222 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.28B | -0.99% | 3,354,772 | 17.32B |
| 39 | IQV | IQVIA Holdings Inc. | 44.70B | 0.70% | 725,419 | 16.98B |
| 40 | MDLN | Medline Inc. | 43.73B | 3.58% | 4,857,519 | 29.94B |
| 41 | A | Agilent Technologies, Inc. | 43.42B | 2.49% | 985,587 | 7.37B |
| 42 | VEEV | Veeva Systems Inc. | 43.15B | -0.05% | 491,299 | 3.46B |
| 43 | RVMD | Revolution Medicines, Inc. | 42.00B | -4.34% | 1,537,813 | - |
| 44 | WAT | Waters Corporation | 41.29B | 0.75% | 299,835 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.88B | 1.60% | 182,561 | 4.55B |
| 46 | HLN | Haleon plc | 40.25B | -0.27% | 6,435,489 | 14.80B |
| 47 | ONC | BeOne Medicines AG | 39.64B | 0.62% | 137,024 | 6.13B |
| 48 | ILMN | Illumina, Inc. | 34.46B | 2.66% | 2,033,566 | 4.49B |
| 49 | RPRX | Royalty Pharma plc | 33.75B | 0.38% | 1,038,713 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 33.19B | 1.75% | 1,721,053 | 4.97B |
| 51 | CNC | Centene Corporation | 32.97B | -1.34% | 2,315,650 | 180.30B |
| 52 | RMD | ResMed Inc. | 32.71B | -0.36% | 525,299 | 5.65B |
| 53 | ALC | Alcon Inc. | 32.57B | -0.74% | 1,059,843 | 10.86B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.19B | 0.96% | 402,972 | 4.80B |
| 55 | BIIB | Biogen Inc. | 31.89B | -0.14% | 266,439 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 30.31B | -0.11% | 1,643,681 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 28.70B | -0.81% | 1,435,967 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 28.50B | -0.10% | 3,376,850 | 7.53M |
| 59 | MTD | Mettler-Toledo International Inc. | 27.76B | 4.13% | 203,469 | 4.13B |
| 60 | DGX | Quest Diagnostics Incorporated | 27.15B | -0.43% | 459,586 | 11.56B |
| 61 | INSM | Insmed Incorporated | 26.90B | 2.72% | 732,201 | 1.14B |
| 62 | LH | Labcorp Holdings Inc. | 26.12B | -0.57% | 225,012 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.79B | 0.41% | 362,004 | 3.33B |
| 64 | INCY | Incyte Corporation | 25.25B | 2.33% | 522,748 | 5.82B |
| 65 | PHG | Koninklijke Philips N.V. | 24.35B | -0.54% | 381,694 | 20.18B |
| 66 | BNTX | BioNTech SE | 24.12B | -0.71% | 198,347 | 3.03B |
| 67 | GH | Guardant Health, Inc. | 23.62B | 0.20% | 954,696 | 1.18B |
| 68 | THC | Tenet Healthcare Corporation | 21.53B | 2.50% | 311,123 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 21.43B | -0.14% | 240,339 | 3.15B |
| 70 | STE | STERIS plc | 20.69B | 0.94% | 286,517 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.84B | 0.82% | 2,238,746 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.37B | 1.26% | 3,349,268 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.57B | -1.09% | 881,245 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.34B | 0.15% | 97,620 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.23B | 3.07% | 650,111 | 1.20B |
| 76 | RVTY | Revvity, Inc. | 16.21B | 3.60% | 1,952,862 | 2.91B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.78B | 0.95% | 335,772 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.33B | -0.01% | 467,034 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 15.32B | 0.49% | 488,900 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.12B | 0.18% | 944,463 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 13.82B | -0.46% | 3,484,981 | - |
| 82 | ICLR | ICON Public Limited Company | 13.54B | 1.73% | 405,998 | 8.29B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.24B | -0.94% | 2,012,184 | 713.07M |
| 84 | CRL | Charles River Laboratories International, Inc. | 13.13B | 0.79% | 397,211 | 4.00B |
| 85 | PEN | Penumbra, Inc. | 12.57B | 0.20% | 436,609 | 1.50B |
| 86 | TEM | Tempus AI, Inc. | 12.57B | 1.15% | 5,911,089 | 1.43B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.56B | 0.70% | 1,161,424 | 3.41B |
| 88 | DVA | DaVita Inc. | 12.39B | 1.75% | 251,989 | 14.01B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.38B | 1.00% | 744,694 | 14.37B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.26B | 1.66% | 980,678 | 1.66B |
| 91 | EHC | Encompass Health Corporation | 12.25B | 1.82% | 385,669 | 6.21B |
| 92 | FMS | Fresenius Medical Care AG | 12.17B | 0.30% | 224,499 | 22.19B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.15B | 0.50% | 134,083 | 1.28B |
| 94 | BAX | Baxter International Inc. | 12.14B | -0.99% | 6,718,375 | 11.47B |
| 95 | CORT | Corcept Therapeutics Incorporated | 12.10B | 0.98% | 245,046 | 830.81M |
| 96 | SNN | Smith & Nephew plc | 11.79B | -0.61% | 625,095 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.57B | 0.70% | 3,396,933 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.33B | -0.10% | 2,498,059 | 1.22B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.03B | 3.15% | 446,591 | 776.57M |
| 100 | ALGN | Align Technology, Inc. | 10.75B | 2.92% | 558,655 | 4.14B |
| 101 | MOH | Molina Healthcare, Inc. | 10.74B | -0.36% | 263,672 | 42.47B |
| 102 | UHS | Universal Health Services, Inc. | 10.65B | 2.21% | 376,461 | 18.11B |
| 103 | AVTR | Avantor, Inc. | 10.52B | 0.71% | 6,740,137 | 6.56B |
| 104 | COO | The Cooper Companies, Inc. | 10.40B | 2.68% | 3,302,699 | 4.24B |
| 105 | ENSG | The Ensign Group, Inc. | 10.26B | 2.77% | 168,588 | 5.49B |
| 106 | BIO | Bio-Rad Laboratories, Inc. | 10.24B | 1.27% | 120,738 | 2.59B |
| 107 | GMED | Globus Medical, Inc. | 10.16B | 1.33% | 597,151 | 3.14B |
| 108 | KRYS | Krystal Biotech, Inc. | 10.09B | 1.21% | 87,765 | 440.48M |
| 109 | OSCR | Oscar Health, Inc. | 10.05B | 0.43% | 3,878,748 | 15.32B |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 9.94B | 0.87% | 1,771,203 | 3.50B |
| 111 | PODD | Insulet Corporation | 9.87B | 2.23% | 738,379 | 3.05B |
| 112 | RGEN | Repligen Corporation | 9.80B | -0.58% | 384,771 | 785.10M |
| 113 | HSIC | Henry Schein, Inc. | 9.74B | -0.16% | 437,873 | 13.60B |
| 114 | KYMR | Kymera Therapeutics, Inc. | 9.71B | 3.20% | 380,202 | 105.00M |
| 115 | CYTK | Cytokinetics, Incorporated | 9.70B | 0.71% | 558,396 | 67.67M |
| 116 | GKOS | Glaukos Corporation | 9.67B | -4.49% | 362,002 | 612.84M |
| 117 | TXG | 10x Genomics, Inc. | 9.61B | -0.89% | 1,991,637 | 616.91M |
| 118 | ABVX | ABIVAX Société Anonyme | 9.44B | -3.11% | 1,419,729 | 5.67M |
| 119 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.38B | -6.04% | 3,227,861 | 669.50M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.29B | 0.09% | 186,987 | 281.99M |
| 121 | BRKR | Bruker Corporation | 9.24B | 8.75% | 2,842,328 | 3.50B |
| 122 | QGEN | Qiagen N.V. | 8.96B | 1.98% | 793,965 | 2.10B |
| 123 | PCVX | Vaxcyte, Inc. | 8.84B | 0.34% | 668,110 | - |
| 124 | TWST | Twist Bioscience Corporation | 8.82B | 1.85% | 1,472,094 | 431.80M |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 8.54B | -2.21% | 295,134 | 7.46M |
| 126 | IBRX | ImmunityBio, Inc. | 8.27B | -4.18% | 5,509,416 | 165.79M |
| 127 | CAI | Caris Life Sciences, Inc. | 8.03B | -0.25% | 2,694,760 | 989.61M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 8.03B | 0.10% | 428,234 | - |
| 129 | HQY | HealthEquity, Inc. | 7.99B | 0.12% | 359,413 | 1.36B |
| 130 | ATR | AptarGroup, Inc. | 7.93B | 0.08% | 191,302 | 3.93B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.84B | 4.26% | 1,569,418 | 799.54M |
| 132 | ALKS | Alkermes plc | 7.72B | -0.09% | 884,348 | 1.67B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.52B | -4.21% | 4,118,670 | 874.09M |
| 134 | IMVT | Immunovant, Inc. | 7.51B | -0.79% | 551,346 | - |
| 135 | HNGE | Hinge Health, Inc. | 7.51B | 0.69% | 669,982 | 720.06M |
| 136 | BLTE | Belite Bio, Inc | 6.81B | -0.27% | 71,117 | - |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.80B | 2.12% | 569,891 | 239.92M |
| 138 | PACS | PACS Group, Inc. | 6.75B | 1.24% | 614,771 | 5.55B |
| 139 | CHE | Chemed Corporation | 6.66B | 1.08% | 69,536 | 2.60B |
| 140 | GRFS | Grifols, S.A. | 6.64B | - | 226,408 | 8.48B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.57B | -0.06% | 267,381 | 1.56B |
| 142 | CGON | CG Oncology, Inc. | 6.55B | 1.82% | 297,391 | 6.23M |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.49B | -0.07% | 4,827,663 | 2.58B |
| 144 | AMRX | Amneal Pharmaceuticals, Inc. | 6.30B | 8.71% | 2,752,154 | 3.12B |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.29B | 3.09% | 401,444 | 618.07M |
| 146 | MMED | MiniMed Group, Inc. | 6.26B | 1.14% | 2,969,616 | 3.22B |
| 147 | ORKA | Oruka Therapeutics, Inc. | 6.20B | 1.54% | 402,466 | - |
| 148 | LQDA | Liquidia Corporation | 6.19B | 5.25% | 584,484 | 450.91M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.14B | -0.17% | 88,991 | 5.32B |
| 150 | STVN | Stevanato Group S.p.A. | 6.09B | 3.57% | 454,471 | 1.40B |
| 151 | RDNT | RadNet, Inc. | 6.06B | -0.07% | 398,608 | 2.27B |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.99B | 2.14% | 213,635 | 840.85M |
| 153 | TVTX | Travere Therapeutics, Inc. | 5.97B | 1.39% | 1,231,230 | 591.33M |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.95B | -2.34% | 2,315,157 | - |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 5.78B | -1.35% | 306,588 | 1.90M |
| 156 | COGT | Cogent Biosciences, Inc. | 5.65B | -0.58% | 1,169,630 | - |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.59B | 1.95% | 726,625 | 1.01B |
| 158 | SHC | Sotera Health Company | 5.54B | 2.37% | 1,035,586 | 1.22B |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.53B | 1.49% | 432,673 | 7.50M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 5.47B | -0.87% | 187,825 | 290.54M |
| 161 | TFX | Teleflex Incorporated | 5.47B | 0.11% | 345,138 | 2.25B |
| 162 | ERAS | Erasca, Inc. | 5.44B | -4.31% | 2,552,471 | - |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.18B | 0.59% | 182,509 | 1.58B |
| 164 | WAY | Waystar Holding Corp. | 5.15B | 0.71% | 1,985,188 | 1.21B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.11B | 3.23% | 1,098,946 | - |
| 166 | CRSP | CRISPR Therapeutics AG | 5.05B | 0.81% | 1,850,243 | 13.39M |
| 167 | LFST | LifeStance Health Group, Inc. | 4.95B | -0.84% | 2,961,037 | 1.58B |
| 168 | BLLN | BillionToOne, Inc. | 4.95B | 0.58% | 239,735 | 397.41M |
| 169 | EWTX | Edgewise Therapeutics, Inc. | 4.87B | 2.73% | 852,513 | - |
| 170 | HAE | Haemonetics Corporation | 4.77B | -1.33% | 223,548 | 1.35B |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.75B | 3.03% | 569,747 | 1.14B |
| 172 | DOCS | Doximity, Inc. | 4.67B | 1.43% | 836,547 | 655.57M |
| 173 | CON | Concentra Group Holdings Parent, Inc. | 4.64B | 2.23% | 346,806 | 2.29B |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.48B | 1.57% | 730,120 | 148.00K |
| 175 | IOVA | Iovance Biotherapeutics, Inc. | 4.40B | 3.85% | 12,351,932 | 324.97M |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.33B | 1.80% | 3,084,036 | 308.08M |
| 177 | LIVN | LivaNova PLC | 4.33B | -1.21% | 321,212 | 1.47B |
| 178 | ITGR | Integer Holdings Corporation | 4.29B | 0.01% | 460,608 | 1.84B |
| 179 | MANE | Veradermics, Incorporated | 4.27B | -1.59% | 395,564 | - |
| 180 | HTFL | HeartFlow, Inc. | 4.21B | 0.21% | 630,680 | 212.07M |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.15B | -0.16% | 932,877 | 10.35M |
| 182 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.14B | -0.60% | 862,517 | -665.00K |
| 183 | TLX | Telix Pharmaceuticals Limited | 4.09B | -7.87% | 561,357 | 890.79M |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.05B | 0.29% | 971,004 | 1.33B |
| 185 | CELC | Celcuity Inc. | 4.04B | -0.06% | 362,555 | - |
| 186 | NVST | Envista Holdings Corporation | 4.03B | 1.37% | 1,920,086 | 2.86B |
| 187 | ICUI | ICU Medical, Inc. | 3.96B | 1.50% | 84,507 | 2.16B |
| 188 | TNGX | Tango Therapeutics, Inc. | 3.94B | -2.26% | 2,067,800 | 53.81M |
| 189 | IRTC | iRhythm Holdings, Inc. | 3.76B | 1.92% | 268,945 | 825.34M |
| 190 | ABCL | AbCellera Biologics Inc. | 3.72B | 0.53% | 2,192,776 | 66.17M |
| 191 | OPCH | Option Care Health, Inc. | 3.70B | 5.06% | 1,908,873 | 5.69B |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | 0.03% | 303,885 | 234.13M |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.62B | -8.13% | 684,299 | 1.19M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.61B | -7.66% | 1,701,668 | - |
| 195 | OGN | Organon & Co. | 3.59B | 0.11% | 1,120,653 | 6.13B |
| 196 | NHC | National HealthCare Corporation | 3.55B | 0.07% | 29,037 | 1.56B |
| 197 | TARS | Tarsus Pharmaceuticals, Inc. | 3.46B | 0.72% | 309,989 | 606.33M |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.43B | -1.92% | 1,786,931 | - |
| 199 | GRAL | GRAIL, Inc. | 3.37B | -0.57% | 1,167,623 | 165.26M |
| 200 | LEGN | Legend Biotech Corporation | 3.28B | -4.24% | 2,652,270 | 1.27B |
| 201 | DNLI | Denali Therapeutics Inc. | 3.26B | 0.10% | 1,003,087 | 3.60M |
| 202 | DYN | Dyne Therapeutics, Inc. | 3.23B | -3.35% | 1,047,952 | - |
| 203 | AVAH | Aveanna Healthcare Holdings Inc. | 3.20B | 2.62% | 1,227,416 | 2.60B |
| 204 | VCYT | Veracyte, Inc. | 3.16B | -1.94% | 601,974 | 561.90M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.15B | 1.81% | 1,090,915 | 117.00M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.14B | 6.21% | 2,735,420 | 463.98M |
| 207 | CLDX | Celldex Therapeutics, Inc. | 3.04B | 0.42% | 526,319 | 158.00K |
| 208 | TMDX | TransMedics Group, Inc. | 3.01B | -1.48% | 225,921 | 668.47M |
| 209 | QURE | uniQure N.V. | 2.96B | -0.90% | 656,545 | 18.67M |
| 210 | WRBY | Warby Parker Inc. | 2.94B | -2.26% | 1,574,304 | 911.61M |
| 211 | WGS | GeneDx Holdings Corp. | 2.94B | 4.09% | 440,952 | 454.43M |
| 212 | GRDN | Guardian Pharmacy Services, Inc. | 2.91B | -4.33% | 529,529 | 1.46B |
| 213 | MBX | MBX Biosciences, Inc. | 2.91B | -1.23% | 863,932 | - |
| 214 | ATRC | AtriCure, Inc. | 2.88B | 0.85% | 624,260 | 569.62M |
| 215 | BKD | Brookdale Senior Living Inc. | 2.84B | 0.21% | 1,505,515 | 2.93B |
| 216 | CDNA | CareDx, Inc. | 2.78B | 1.90% | 528,882 | 458.09M |
| 217 | ZLAB | Zai Lab Limited | 2.77B | -0.52% | 880,497 | 449.61M |
| 218 | NEOG | Neogen Corporation | 2.77B | 3.67% | 1,523,050 | 870.40M |
| 219 | RGC | Regencell Bioscience Holdings Limited | 2.73B | -1.79% | 100,316 | - |
| 220 | IMNM | Immunome, Inc. | 2.71B | -0.21% | 615,907 | 4.02M |
| 221 | AXGN | Axogen, Inc. | 2.66B | 0.91% | 777,921 | 251.17M |
| 222 | IRON | Disc Medicine, Inc. | 2.65B | 2.53% | 248,949 | - |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.63B | 3.18% | 360,593 | 3.37B |
| 224 | PHVS | Pharvaris N.V. | 2.63B | -1.58% | 435,418 | - |
| 225 | PRVA | Privia Health Group, Inc. | 2.62B | 0.79% | 658,443 | 2.36B |
| 226 | PGEN | Precigen, Inc. | 2.62B | 4.57% | 3,117,485 | 85.72M |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.60B | 0.81% | 621,082 | 36.77M |
| 228 | GPCR | Structure Therapeutics Inc. | 2.57B | -7.37% | 644,083 | - |
| 229 | NAMS | NewAmsterdam Pharma Company N.V. | 2.53B | -0.05% | 691,383 | 7.12M |
| 230 | HRMY | Harmony Biosciences Holdings, Inc. | 2.48B | 1.19% | 771,743 | 959.90M |
| 231 | VRDN | Viridian Therapeutics, Inc. | 2.47B | - | 686,040 | 71.13M |
| 232 | CLOV | Clover Health Investments, Corp. | 2.46B | -0.43% | 2,181,889 | 2.48B |
| 233 | NEO | NeoGenomics, Inc. | 2.46B | 1.27% | 776,495 | 766.30M |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | -4.84% | 577,449 | - |
| 235 | SUPN | Supernus Pharmaceuticals, Inc. | 2.42B | 0.92% | 394,149 | 830.44M |
| 236 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | 1.77% | 3,440,405 | - |
| 237 | VERA | Vera Therapeutics, Inc. | 2.28B | -6.09% | 2,556,777 | - |
| 238 | BEAM | Beam Therapeutics Inc. | 2.28B | -1.81% | 872,492 | 156.04M |
| 239 | NKTR | Nektar Therapeutics | 2.27B | -0.29% | 324,876 | 54.59M |
| 240 | HCM | HUTCHMED (China) Limited | 2.27B | -2.90% | 16,561 | 549.12M |
| 241 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | 1.02% | 242,352 | 1.10B |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | 3.29% | 433,939 | 311.51M |
| 243 | PVLA | Palvella Therapeutics, Inc. | 2.20B | 0.85% | 112,251 | - |
| 244 | UFPT | UFP Technologies, Inc. | 2.19B | 2.63% | 68,971 | 631.64M |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.18B | -2.45% | 2,387,932 | 52.06M |
| 246 | ADUS | Addus HomeCare Corporation | 2.17B | 2.26% | 97,355 | 1.48B |
| 247 | TRLV | Trulieve Cannabis Corp. | 2.17B | -3.02% | 787,419 | 1.14B |
| 248 | ESTA | Establishment Labs Holdings Inc. | 2.14B | 0.64% | 121,059 | 245.82M |
| 249 | ZBIO | Zenas BioPharma, Inc. | 2.14B | 2.91% | 357,673 | 1.00M |
| 250 | TRVI | Trevi Therapeutics, Inc. | 2.14B | -0.07% | 1,385,826 | - |
| 251 | INSP | Inspire Medical Systems, Inc. | 2.14B | -0.78% | 407,498 | 898.74M |
| 252 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.13B | 2.33% | 2,275,538 | 940.61M |
| 253 | BHC | Bausch Health Companies Inc. | 2.13B | 0.53% | 986,894 | 10.85B |
| 254 | URGN | UroGen Pharma Ltd. | 2.11B | 3.23% | 440,335 | 188.73M |
| 255 | SRPT | Sarepta Therapeutics, Inc. | 2.11B | -3.76% | 1,433,463 | 1.97B |
| 256 | PGNY | Progyny, Inc. | 2.09B | -1.73% | 510,863 | 1.31B |
| 257 | MD | Pediatrix Medical Group, Inc. | 2.08B | -1.57% | 249,695 | 1.95B |
| 258 | VCEL | Vericel Corporation | 2.08B | 2.22% | 272,067 | 306.30M |
| 259 | ALMR | Alamar Biosciences, Inc. | 2.05B | 2.57% | 277,043 | 100.42M |
| 260 | KOD | Kodiak Sciences Inc. | 2.04B | -1.30% | 373,774 | - |
| 261 | XRAY | DENTSPLY SIRONA Inc. | 2.03B | 3.56% | 2,991,123 | 3.64B |
| 262 | GENB | Generate Biomedicines, Inc. | 2.02B | -2.78% | 585,036 | 26.48M |
| 263 | NUVB | Nuvation Bio Inc. | 2.02B | -0.86% | 1,343,539 | 169.90M |
| 264 | RAPP | Rapport Therapeutics, Inc. | 2.01B | -1.99% | 167,117 | 20.00M |
| 265 | ADMA | ADMA Biologics, Inc. | 2.00B | 3.48% | 1,141,669 | 512.28M |
| 266 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | 1.46% | 442,635 | 98.34M |
| 267 | COAG | Hemab Therapeutics Holdings, Inc. | 1.98B | 5.51% | 323,915 | - |
| 268 | ASTH | Astrana Health, Inc. | 1.95B | -0.50% | 118,201 | 3.84B |
| 269 | CMPS | COMPASS Pathways plc | 1.92B | 0.51% | 1,484,277 | - |
| 270 | GHRS | GH Research PLC | 1.91B | 0.83% | 86,301 | - |
| 271 | FTRE | Fortrea Holdings Inc. | 1.90B | 1.37% | 1,357,145 | 2.68B |
| 272 | ALVO | Alvotech | 1.90B | 5.78% | 2,520,257 | 494.61M |
| 273 | PRGO | Perrigo Company plc | 1.89B | 0.48% | 966,369 | 4.14B |
| 274 | MESO | Mesoblast Limited | 1.89B | -1.76% | 162,234 | 120.25M |
| 275 | BFLY | Butterfly Network, Inc. | 1.89B | -9.23% | 2,973,917 | 112.14M |
| 276 | NVCR | NovoCure Limited | 1.88B | -0.19% | 557,502 | 699.19M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.40% | 182,664 | 481.07M |
| 278 | ZYME | Zymeworks Inc. | 1.85B | 0.04% | 314,184 | 37.13M |
| 279 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 0.75% | 155,491 | 262.43M |
| 280 | BHVN | Biohaven Ltd. | 1.83B | -1.62% | 1,291,307 | - |
| 281 | SGRY | Surgery Partners, Inc. | 1.83B | 3.37% | 672,226 | 3.37B |
| 282 | ALHC | Alignment Healthcare, Inc. | 1.82B | -15.43% | 15,885,256 | 4.58B |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.81B | -0.25% | 176,677 | 27.59M |
| 284 | LKFT | Lakefront Biotherapeutics NV | 1.80B | -0.18% | 281,585 | 1.13B |
| 285 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.78B | -0.15% | 879,294 | 208.78M |
| 286 | VIR | Vir Biotechnology, Inc. | 1.78B | 0.96% | 966,574 | 303.23M |
| 287 | SDGR | Schrödinger, Inc. | 1.78B | 2.37% | 1,623,468 | 259.04M |
| 288 | XNCR | Xencor, Inc. | 1.78B | 0.63% | 373,433 | 104.97M |
| 289 | SEPN | Septerna, Inc. | 1.77B | -2.21% | 128,007 | 98.88M |
| 290 | BLFS | BioLife Solutions, Inc. | 1.77B | -0.52% | 268,603 | 106.69M |
| 291 | NBTX | Nanobiotix S.A. | 1.76B | -3.49% | 172,630 | 38.27M |
| 292 | BRVE | Braveheart Bio, Inc. | 1.75B | 2.10% | 276,329 | - |
| 293 | PSNL | Personalis, Inc. | 1.72B | 0.25% | 1,183,158 | 69.67M |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -1.54% | 10,261,969 | 54.86M |
| 295 | TYRA | Tyra Biosciences, Inc. | 1.67B | -4.48% | 653,493 | - |
| 296 | KARD | Kardigan, Inc. | 1.65B | -4.74% | 569,320 | - |
| 297 | KLRA | Kailera Therapeutics, Inc. | 1.64B | -5.69% | 516,399 | - |
| 298 | ATEC | Alphatec Holdings, Inc. | 1.64B | -0.61% | 1,081,417 | 815.05M |
| 299 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | -0.79% | 1,371,728 | 5.49M |
| 300 | IMCR | Immunocore Holdings plc | 1.61B | -1.56% | 275,537 | 430.78M |
| 301 | NTLA | Intellia Therapeutics, Inc. | 1.61B | 1.06% | 1,942,410 | 59.51M |
| 302 | ANAB | AnaptysBio, Inc. | 1.61B | -0.76% | 145,574 | 232.39M |
| 303 | ETON | Eton Pharmaceuticals, Inc. | 1.60B | 1.66% | 156,547 | 105.60M |
| 304 | FRNM | Freenome, Inc. | 1.58B | 0.75% | 278,236 | 35.41M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | 2.14% | 225,263 | 978.38M |
| 306 | SNDX | Syndax Pharmaceuticals, Inc. | 1.55B | -3.81% | 1,261,746 | 252.25M |
| 307 | DMRA | Damora Therapeutics, Inc. | 1.54B | 0.61% | 786,009 | - |
| 308 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | 0.56% | 211,967 | - |
| 309 | AVLN | Avalyn Pharma Inc. | 1.53B | 0.88% | 95,572 | - |
| 310 | NUTX | Nutex Health Inc. | 1.53B | 3.91% | 91,987 | 846.72M |
| 311 | INVA | Innoviva, Inc. | 1.52B | 1.25% | 368,085 | 440.00M |
| 312 | AGL | agilon health, inc. | 1.52B | -1.46% | 73,156 | 5.92B |
| 313 | NVAX | Novavax, Inc. | 1.52B | - | 1,606,532 | 413.80M |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.51B | 0.64% | 201,918 | 1.86B |
| 315 | ARDT | Ardent Health, Inc. | 1.51B | 0.09% | 237,112 | 6.41B |
| 316 | INBX | Inhibrx Biosciences, Inc. | 1.50B | -3.67% | 180,529 | 1.30M |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.48B | -1.15% | 399,888 | - |
| 318 | INNV | InnovAge Holding Corp. | 1.48B | -0.73% | 114,930 | 989.71M |
| 319 | PNTG | The Pennant Group, Inc. | 1.48B | 5.73% | 837,555 | 1.10B |
| 320 | OMCL | Omnicell, Inc. | 1.47B | -0.95% | 201,147 | 1.25B |
| 321 | AZTA | Azenta, Inc. | 1.46B | 0.76% | 288,454 | 613.81M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.45B | -3.10% | 565,008 | 106.73M |
| 323 | PAHC | Phibro Animal Health Corporation | 1.44B | 1.31% | 143,058 | 1.52B |
| 324 | XERS | Xeris Biopharma Holdings, Inc. | 1.43B | 4.81% | 943,117 | 335.41M |
| 325 | KRSA | Korsana Biosciences, Inc. | 1.43B | -2.12% | 30,798 | - |
| 326 | CNMD | CONMED Corporation | 1.42B | 0.89% | 141,987 | 1.37B |
| 327 | AAPG | Ascentage Pharma Group International | 1.41B | -3.75% | 2,551 | 94.61M |
| 328 | TRAX | First Tracks Biotherapeutics, Inc. | 1.40B | 1.59% | 360,185 | - |
| 329 | DRTS | Alpha Tau Medical Ltd. | 1.38B | 0.67% | 463,434 | - |
| 330 | LBRX | LB Pharmaceuticals Inc | 1.38B | -0.77% | 82,538 | - |
| 331 | ABSI | Absci Corporation | 1.36B | -0.25% | 1,393,257 | 1.56M |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.36B | 2.69% | 236,333 | 3.43B |
| 333 | MAZE | Maze Therapeutics, Inc. | 1.35B | 0.08% | 224,151 | 20.00M |
| 334 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -2.40% | 159,908 | - |
| 335 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 0.88% | 373,014 | - |
| 336 | SVRA | Savara Inc. | 1.31B | -2.00% | 604,059 | - |
| 337 | VOR | Vor Biopharma Inc. | 1.30B | -1.43% | 988,146 | - |
| 338 | ORIC | ORIC Pharmaceuticals, Inc. | 1.30B | 1.50% | 778,488 | - |
| 339 | OMER | Omeros Corporation | 1.29B | 4.02% | 821,973 | 38.42M |
| 340 | HROW | Harrow, Inc. | 1.28B | 0.53% | 203,621 | 275.59M |
| 341 | CERT | Certara, Inc. | 1.27B | -0.89% | 1,022,487 | 421.75M |
| 342 | RARE | Ultragenyx Pharmaceutical Inc. | 1.27B | -1.38% | 2,455,534 | 717.00M |
| 343 | IART | Integra LifeSciences Holdings Corporation | 1.25B | 2.23% | 800,337 | 1.65B |
| 344 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 2.23% | 88,102 | 804.27M |
| 345 | MGTX | MeiraGTx Holdings plc | 1.23B | 0.24% | 535,580 | 397.50M |
| 346 | AORT | Artivion, Inc. | 1.23B | -0.99% | 281,541 | 471.47M |
| 347 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | 8.11% | 1,916,722 | 1.04B |
| 348 | REPL | Replimune Group, Inc. | 1.21B | -1.46% | 911,826 | - |
| 349 | OPK | OPKO Health, Inc. | 1.21B | 3.18% | 1,446,689 | 587.90M |
| 350 | OMDA | Omada Health, Inc. | 1.21B | 0.20% | 370,260 | 309.76M |
| 351 | SPTX | Seaport Therapeutics, Inc. | 1.20B | -2.57% | 158,833 | - |
| 352 | IMTX | Immatics N.V. | 1.19B | 1.40% | 403,339 | 47.65M |
| 353 | AKTS | Aktis Oncology, Inc. | 1.19B | -4.60% | 370,486 | 10.06M |
| 354 | ANRO | Alto Neuroscience, Inc. | 1.18B | -0.33% | 279,726 | - |
| 355 | CRON | Cronos Group Inc. | 1.18B | 2.97% | 778,639 | 179.09M |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.18B | -0.86% | 274,862 | 785.23M |
| 357 | TDOC | Teladoc Health, Inc. | 1.16B | -2.74% | 1,341,471 | 2.49B |
| 358 | MNKD | MannKind Corporation | 1.14B | -0.28% | 1,045,093 | 393.63M |
| 359 | STAA | STAAR Surgical Company | 1.14B | 1.36% | 363,571 | 339.59M |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -0.59% | 66,183 | 1.04B |
| 361 | APMD | Apnimed, Inc. | 1.12B | 5.63% | 330,382 | 115.12M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.12B | 1.09% | 650,766 | 337.34M |
| 363 | BVS | Bioventus Inc. | 1.12B | 2.08% | 144,321 | 581.85M |
| 364 | CSTL | Castle Biosciences, Inc. | 1.10B | 1.77% | 283,269 | 357.28M |
| 365 | ODTX | Odyssey Therapeutics, Inc. | 1.10B | 4.41% | 336,301 | 99.00K |
| 366 | GLUE | Monte Rosa Therapeutics, Inc. | 1.08B | -2.85% | 795,079 | 28.73M |
| 367 | ENOV | Enovis Corporation | 1.08B | 4.01% | 822,373 | 2.30B |
| 368 | IRMD | IRADIMED CORPORATION | 1.06B | 0.59% | 74,556 | 86.34M |
| 369 | OBX | Obsidian Therapeutics, Inc. | 1.05B | 0.41% | 611,228 | - |
| 370 | SLBT | SL Science Holding Limited | 1.04B | -4.19% | 127,369 | 3.27M |
| 371 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -4.63% | 474,515 | - |
| 372 | JBIO | Jade Biosciences, Inc. | 1.04B | -6.21% | 807,407 | - |
| 373 | ALMS | Alumis Inc. | 1.03B | -5.60% | 2,635,281 | 7.40M |
| 374 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.03B | 1.99% | 217,524 | 730.02M |
| 375 | MLTX | MoonLake Immunotherapeutics | 1.02B | -1.48% | 1,246,404 | - |
| 376 | GMRS | GMR Solutions Inc. | 1.02B | 3.14% | 1,667,801 | 5.88B |
| 377 | ATTO | Attovia Therapeutics, Inc. | 1.00B | -7.17% | 100,247 | 1.80M |
| 378 | KURA | Kura Oncology, Inc. | 1.00B | -0.44% | 821,177 | 77.23M |
| 379 | ABUS | Arbutus Biopharma Corporation | 997.15M | -0.40% | 2,173,344 | 181.72M |
| 380 | PCRX | Pacira BioSciences, Inc. | 984.79M | 2.60% | 316,739 | 746.16M |
| 381 | JANX | Janux Therapeutics, Inc. | 983.69M | -2.13% | 565,694 | 24.00M |
| 382 | ANL | Adlai Nortye Group Ltd. | 982.71M | 1.73% | 125,003 | 18.06M |
| 383 | HELP | Cybin Inc. | 979.74M | 2.21% | 630,447 | - |
| 384 | SGP | SpyGlass Pharma, Inc. | 958.28M | -1.07% | 67,288 | - |
| 385 | BBNX | Beta Bionics, Inc. | 956.03M | 10.50% | 4,599,400 | 119.01M |
| 386 | CBLL | CeriBell, Inc. | 951.78M | -0.96% | 248,070 | 101.96M |
| 387 | SLDB | Solid Biosciences Inc. | 917.85M | 2.27% | 1,409,409 | - |
| 388 | IVA | Inventiva S.A. | 903.84M | -2.20% | 1,904,222 | 7.94M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 903.26M | 1.00% | 1,402,691 | 41.47M |
| 390 | SANA | Sana Biotechnology, Inc. | 902.57M | -4.59% | 1,774,048 | - |
| 391 | FTH | Faeth Therapeutics, Inc. | 901.31M | -1.39% | 171,188 | - |
| 392 | TBPH | Theravance Biopharma, Inc. | 884.18M | -0.06% | 131,232 | 104.31M |
| 393 | WVE | Wave Life Sciences, Inc. | 876.86M | -0.22% | 1,223,651 | 65.37M |
| 394 | AVTX | Avalo Therapeutics, Inc. | 873.10M | 1.31% | 676,472 | 59.00K |
| 395 | HSTM | HealthStream, Inc. | 865.21M | -0.20% | 64,076 | 321.12M |
| 396 | IMMX | Immix Biopharma, Inc. | 851.32M | -1.98% | 932,829 | - |
| 397 | RIGL | Rigel Pharmaceuticals, Inc. | 845.73M | 2.06% | 119,564 | 276.79M |
| 398 | INMD | InMode Ltd. | 841.81M | -1.51% | 542,500 | 374.63M |
| 399 | CADL | Candel Therapeutics, Inc. | 840.94M | -1.17% | 786,410 | - |
| 400 | ARDX | Ardelyx, Inc. | 839.76M | -0.88% | 2,199,947 | 450.89M |
| 401 | SIBN | SI-BONE, Inc. | 834.97M | 0.43% | 184,901 | 213.60M |
| 402 | GERN | Geron Corporation | 832.00M | -1.15% | 4,354,152 | 204.56M |
| 403 | OLMA | Olema Pharmaceuticals, Inc. | 831.23M | -2.86% | 540,218 | - |
| 404 | BLSM | BlossomHill Therapeutics, Inc. | 811.44M | 19.44% | 189,965 | - |
| 405 | AVR | Anteris Technologies Global Corp. | 810.85M | -0.24% | 254,650 | 2.24M |
| 406 | CLYM | Climb Bio, Inc. | 802.96M | 0.50% | 1,262,996 | - |
| 407 | AHCO | AdaptHealth Corp. | 797.79M | 2.75% | 1,035,400 | 3.36B |
| 408 | DSGN | Design Therapeutics, Inc. | 782.27M | 2.25% | 515,619 | - |
| 409 | VREX | Varex Imaging Corporation | 778.89M | 0.05% | 371,775 | 865.00M |
| 410 | FDMT | 4D Molecular Therapeutics, Inc. | 762.37M | 1.25% | 353,564 | 92.01M |
| 411 | QDEL | QuidelOrtho Corporation | 760.50M | 4.33% | 984,118 | 2.67B |
| 412 | ACHV | Achieve Life Sciences, Inc. | 757.36M | 0.55% | 1,147,658 | - |
| 413 | CBIO | Crescent Biopharma, Inc. | 754.58M | -6.22% | 355,929 | 11.88M |
| 414 | PHAR | Pharming Group N.V. | 750.09M | 0.28% | 55,631 | 366.48M |
| 415 | GLAS | Glass House Brands Inc. | 746.40M | -1.49% | 392,255 | 176.98M |
| 416 | ANNX | Annexon, Inc. | 745.99M | 0.38% | 3,078,108 | - |
| 417 | SLN | Silence Therapeutics plc | 744.49M | -0.76% | 465,055 | 615.00K |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 735.26M | -9.59% | 2,231,572 | 8.22M |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 732.50M | 3.02% | 695,254 | 808.21M |
| 420 | DBVT | DBV Technologies S.A. | 715.71M | 0.68% | 135,380 | 5.04M |
| 421 | GYRE | Gyre Therapeutics, Inc. | 706.72M | -0.37% | 61,488 | 109.82M |
| 422 | NVCT | Nuvectis Pharma, Inc. | 698.22M | -2.24% | 81,998 | - |
| 423 | IRWD | Ironwood Pharmaceuticals, Inc. | 695.66M | 3.69% | 761,262 | 389.32M |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 691.82M | - | 443,265 | 136.07M |
| 425 | MDXG | MiMedx Group, Inc. | 687.99M | - | 573,169 | 355.17M |
| 426 | MNPR | Monopar Therapeutics Inc. | 687.93M | -1.76% | 49,704 | - |
| 427 | AURA | Aura Biosciences, Inc. | 687.56M | -4.19% | 764,940 | - |
| 428 | SOPH | SOPHiA GENETICS SA | 681.02M | 0.50% | 1,258,358 | 86.17M |
| 429 | NGNE | Neurogene Inc. | 677.79M | 0.53% | 94,019 | 925.00K |
| 430 | STLN | Starling Oncology, Inc. | 671.12M | 3.38% | 803,447 | 587.24M |
| 431 | SSII | SS Innovations International, Inc. | 658.27M | -0.45% | 51,363 | 52.40M |
| 432 | VSTM | Verastem, Inc. | 657.49M | -1.09% | 815,481 | 87.53M |
| 433 | SGMT | Sagimet Biosciences Inc. | 643.96M | -0.96% | 339,454 | - |
| 434 | ANGO | AngioDynamics, Inc. | 643.55M | -0.70% | 213,747 | 320.17M |
| 435 | MPLT | MapLight Therapeutics, Inc. | 643.01M | -4.22% | 226,096 | - |
| 436 | AHG | Akso Health Group | 640.81M | -1.58% | 8,554 | 13.83M |
| 437 | CTKB | Cytek Biosciences, Inc. | 635.62M | - | 940,083 | 206.71M |
| 438 | PHR | Phreesia, Inc. | 634.99M | -1.16% | 259,064 | 507.79M |
| 439 | ALT | Altimmune, Inc. | 631.21M | 0.46% | 2,052,844 | 31.00K |
| 440 | OABI | OmniAb, Inc. | 628.81M | -0.57% | 438,743 | 38.46M |
| 441 | PHAT | Phathom Pharmaceuticals, Inc. | 627.50M | -3.19% | 1,183,235 | 239.66M |
| 442 | VALN | Valneva SE | 617.63M | -0.38% | 23,526 | 163.30M |
| 443 | OCS | Oculis Holding AG | 617.32M | -0.70% | 204,768 | 1.45M |
| 444 | CRMD | CorMedix Inc. | 611.86M | 1.16% | 357,755 | 462.25M |
| 445 | KIDS | OrthoPediatrics Corp. | 604.18M | -0.43% | 103,381 | 252.72M |
| 446 | AQST | Aquestive Therapeutics, Inc. | 597.44M | -1.04% | 893,461 | 54.09M |
| 447 | STTK | Shattuck Labs, Inc. | 597.16M | -0.34% | 343,037 | 1.00M |
| 448 | DRUG | Bright Minds Biosciences Inc. | 593.45M | -1.83% | 50,141 | - |
| 449 | CTEV | Claritev Corporation | 592.82M | -1.58% | 35,992 | 994.67M |
| 450 | FLGT | Fulgent Genetics, Inc. | 592.68M | 1.22% | 193,490 | 323.93M |
| 451 | CTMX | CytomX Therapeutics, Inc. | 590.51M | 0.74% | 4,609,331 | 18.30M |
| 452 | WEAV | Weave Communications, Inc. | 586.39M | - | 1,833,377 | 257.79M |
| 453 | ALLO | Allogene Therapeutics, Inc. | 582.15M | -2.03% | 3,731,855 | 4.64M |
| 454 | AGMB | AgomAb Therapeutics NV | 581.13M | -2.96% | 40,454 | - |
| 455 | EVO | Evotec SE | 575.81M | -0.61% | 14,371 | 819.47M |
| 456 | DCTH | Delcath Systems, Inc. | 561.77M | 0.12% | 266,718 | 95.42M |
| 457 | TECX | Tectonic Therapeutic, Inc. | 552.86M | -0.81% | 89,075 | - |
| 458 | PROK | ProKidney Corp. | 550.23M | 4.60% | 1,207,128 | 818.00K |
| 459 | SCTX | Scribe Therapeutics Inc. | 546.94M | -8.75% | 186,657 | 33.30M |
| 460 | CTNM | Contineum Therapeutics, Inc. | 542.87M | 4.41% | 479,914 | - |
| 461 | BWAY | BrainsWay Ltd. | 542.62M | -1.04% | 51,170 | 60.70M |
| 462 | ARVN | Arvinas, Inc. | 531.59M | -1.57% | 336,825 | 316.70M |
| 463 | TLRY | Tilray Brands, Inc. | 531.53M | -2.76% | 2,673,879 | 915.45M |
| 464 | EPRX | Eupraxia Pharmaceuticals Inc. | 530.39M | -0.25% | 105,655 | - |
| 465 | PRME | Prime Medicine, Inc. | 528.38M | -5.41% | 2,063,238 | 4.07M |
| 466 | EOLS | Evolus, Inc. | 522.46M | - | 291,750 | 316.49M |
| 467 | OVID | Ovid Therapeutics Inc. | 521.45M | -1.48% | 965,273 | 1.58M |
| 468 | ENTX | Entera Bio Ltd. | 519.43M | 4.90% | 450,075 | 42.00K |
| 469 | RGNX | REGENXBIO Inc. | 516.22M | -1.57% | 628,690 | 174.48M |
| 470 | ASMB | Assembly Biosciences, Inc. | 516.14M | -2.91% | 194,412 | 74.85M |
| 471 | TCMD | Tactile Systems Technology, Inc. | 514.21M | 0.84% | 299,840 | 350.31M |
| 472 | CERS | Cerus Corporation | 510.87M | 1.40% | 783,901 | 221.55M |
| 473 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 474 | CAPR | Capricor Therapeutics, Inc. | 497.09M | -0.12% | 1,312,853 | 11.13M |
| 475 | AUTL | Autolus Therapeutics plc | 491.07M | -2.38% | 1,348,909 | 117.39M |
| 476 | NRC | NRC Health | 488.62M | 0.59% | 38,251 | 140.00M |
| 477 | NPCE | NeuroPace, Inc. | 488.09M | -0.21% | 51,032 | 106.99M |
| 478 | PBYI | Puma Biotechnology, Inc. | 479.03M | 0.32% | 80,891 | 231.24M |
| 479 | DNA | Ginkgo Bioworks Holdings, Inc. | 478.12M | 1.57% | 634,676 | 132.42M |
| 480 | SENS | Senseonics Holdings, Inc. | 474.81M | 1.13% | 359,126 | 48.55M |
| 481 | EIKN | Eikon Therapeutics, Inc. | 473.94M | -7.80% | 617,003 | - |
| 482 | VOGX | Vogenx, Inc. | 471.67M | 5.22% | 84,456 | - |
| 483 | PRLD | Prelude Therapeutics Incorporated | 464.51M | -0.22% | 107,932 | 22.42M |
| 484 | KMDA | Kamada Ltd. | 463.01M | 1.73% | 92,767 | 191.85M |
| 485 | SRTA | Strata Critical Medical, Inc. | 460.03M | -1.70% | 239,242 | 255.98M |
| 486 | RLMD | Relmada Therapeutics, Inc. | 452.28M | -4.50% | 482,028 | - |
| 487 | IRD | Opus Genetics, Inc. | 450.92M | -6.87% | 1,233,085 | 9.86M |
| 488 | ZURA | Zura Bio Limited | 444.17M | -5.98% | 706,606 | - |
| 489 | SGHT | Sight Sciences, Inc. | 443.46M | -0.74% | 61,947 | 83.38M |
| 490 | ARCT | Arcturus Therapeutics Holdings Inc. | 435.44M | -3.28% | 426,698 | 29.37M |
| 491 | PRTA | Prothena Corporation plc | 433.28M | 1.32% | 252,243 | 54.53M |
| 492 | CCCC | C4 Therapeutics, Inc. | 428.13M | 1.46% | 1,378,283 | 35.04M |
| 493 | CABA | Cabaletta Bio, Inc. | 428.10M | -2.70% | 3,617,980 | - |
| 494 | EVH | Evolent Health, Inc. | 427.36M | 1.07% | 678,218 | 2.10B |
| 495 | KYTX | Kyverna Therapeutics, Inc. | 426.10M | -1.01% | 375,710 | - |
| 496 | ARTV | Artiva Biotherapeutics, Inc. | 421.43M | -3.25% | 317,493 | 251.00K |
| 497 | INDP | Indaptus Therapeutics, Inc. | 418.38M | -13.74% | 1,061,303 | - |
| 498 | PACB | Pacific Biosciences of California, Inc. | 418.07M | 0.37% | 3,843,041 | 159.27M |
| 499 | EDIT | Editas Medicine, Inc. | 416.97M | 3.23% | 1,448,159 | 47.01M |
| 500 | SPRY | ARS Pharmaceuticals, Inc. | 416.68M | -1.41% | 752,797 | 116.93M |